Daniel Howard

A new minority investment, advised by Cabrera Capital, positions engineering leader Cordoba to tackle California's critical infrastructure deficit.

Quebec's pension giant posted a 5.1% mid-year return, trailing its benchmark as an AI boom lifted public stocks while pressuring private equity valuations.

Lurie Children's new facility is more than a pharmacy; it's a look into a new system where hospitals integrate business and care to survive and thrive.

A new partnership is bringing advanced, U.S.-based manufacturing to a rare cancer drug, aiming to solve daily patient challenges and bolster national supply chains.

With a new CFO known for taking tech firms public, Nimble is signaling a new phase for enterprise AI—one where specialized, cost-effective data is the new currency.

The deal is more than a regional expansion; it's a strategic play in a consolidating EHS market, highlighting the industry's race for talent and scale.

A new report from ChargerHelp, built on a massive dataset, is set to expose the real state of EV charging reliability and offer a data-driven path forward.

With 639% growth and a fourth Inc. 5000 nod, Aditude isn't just succeeding; it's rebuilding the publisher monetization playbook from the ground up.

A new platform offers physicians 24/7 access to 'lifelike' AI pharma reps. We analyze the tech, the immense regulatory risks, and the potential to level the playing field.

Climbing the Inc. 5000 list for a second year, Charted's success reveals a deeper story about the power of building technology inside core business systems.

By destroying 13,500 gallons of toxic firefighting foam, Ohio created a model for how states can finally eliminate 'forever chemicals' from our world.

MyFBAPrep joins an elite group with its fourth Inc. 5000 award. We explore how its asset-light model and tech platform are rewriting the rules of logistics.

In a volatile market, investors weigh gold's stability against silver's industrial-driven potential. We dissect the data to help you decide.

With major clinical trials progressing and a $110M war chest, Orchestra BioMed is orchestrating a potential shift in cardiovascular treatment.

AIG's strong Q2 results beat profit estimates, powered by underwriting discipline as it completes its strategic pivot away from Corebridge Financial.

Clipper Realty's latest earnings reveal a stark divide. Record-breaking residential rents are being overshadowed by a major commercial property default.

Ad-tech firm Sabio Holdings secures a $1.5M loan at a staggering 25% interest. Is this a shrewd move to fuel growth or a sign of pressure in a tough market?

Argentina's top cement firm posts a staggering profit jump, but a deeper analysis reveals operational struggles and a construction sector at a crossroads.

With a return to profitability and digital revenue soaring, Lee Enterprises' Q3 results reveal a potent mix of financial strategy and digital transformation.

A landmark deal injects C$31M into Copper Giant’s Mocoa project, securing a path to market and positioning Colombia as a key player in the energy transition.